Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
Stephen Chrzanowski, MD, PhD
Aravindhan Veerapandiyan, MD
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
Christoph U. Correll, MD
Jonathan M. Meyer
Mechanism-Driven gMG Therapy: FcRn Antagonists and the Rise of Precision Neurology
Neelam Goyal, MD
Christyn Edmundson, MD
Advances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
Marwan Sabbagh, MD, FAAN
Alireza Atri, MD, PhD
Treatment of a Broader Population of Patients With DMD
Crystal Proud, MD
Erika Finanger, MD, MS
Advancing Care: Clinical Innovations on the Horizon
John Vissing, MD, DMSci
The Role of Multidisciplinary Care in LGMD2I/R9
Conrad Weihl, MD, PhD
Establishing Our Foundation of LGMD2I/R9
Navigating the LGMD2I/R9 Diagnostic Pathway
Optimizing Patient Management Strategies
Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
James R. Bateman, MD, MPH
B. Joy Snider, MD, PhD
Jerome A. Barakos, MD
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
Charles P. Vega, MD
Clinical Conundrums in ARIA: Differentiating and Navigating ARIA vs Stroke When an Emergent MRI is Unavailable
Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
Clinical Conundrums in ARIA: How to Manage Severe ARIA
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
Clinical Conundrums in ARIA: How to Interpret and Manage ARIA-H
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.